In vitro activity of nitrofuran derivatives on growth and morphology of Salmonella enterica serotype Enteritidis.
OBJECTIVE
To evaluate the effect of nitrofuran derivatives furazolidone (Fz) and nitrofurantoin (Nf) on Salmonella enterica serovar Enteritidis PT4 in vitro, with regard to cell growth, morphology and ultrastructure.


RESULTS
The effects of Fz on the growth rates of Fz resistant (FzR) and sensitive (FzS) strains were assessed by viable counts. Over 24 h incubation, concentrations of <1 microg ml(-1) of Fz were bacteriostatic to the FzS strain. The FzR strain tolerated concentrations up to 16 microg ml(-1) before cell numbers diminished over the same time period. The effect on the growth rate of the FzS strain after 1 h exposure to supra-inhibitory concentrations of Fz, gave a maximum response at 32X minimum inhibitory concentration (MIC) of 4.5 h. Effects on the ultrastructure of bacterial cells by scanning electron and transmission microscopy, and DNA-specific staining with DAPI of the FzS strain exposed to nitrofurans were studied. Abnormalities such as extensive filamentation with sparse, sporadic nucleotide distribution and evidence of extrusions in the cell envelope in the form of blebs were evident.


CONCLUSIONS
Nitrofurans exert their bactericidal effect on Salmonella by inducing extensive structural alteration after exposure at sub- or suprainhibitory concentrations, involving inhibition of cell division because of the activated drug causing an intercalating type of binding in DNA.


CONCLUSIONS
These results demonstrate the in vitro activity of the nitrofuran derivatives, furazolidone and nitrofurantoin on Salmonella, defining the pharmacodynamics and physical nature of their action as therapeutic agents.
Chadfield
M S
MS
Department of Veterinary Microbiology, The Royal Veterinary and Agricultural University, Stigbøjlen, Frederiksberg C, Denmark. mc@kvl.dk
Hinton
M H
MH
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology; D015169:Colony Count, Microbial; D004269:DNA, Bacterial / Q000032:analysis; D004352:Drug Resistance, Microbial; D005516:Food Microbiology; D005664:Furazolidone / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D008854:Microscopy, Electron / Q000379:methods; D016685:Mitomycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology*; D011200:Poultry / Q000382:microbiology; D012477:Salmonella enteritidis / Q000187:drug effects* / Q000254:growth & development / Q000648:ultrastructure
D000890:Anti-Infective Agents; D000892:Anti-Infective Agents, Urinary; D004269:DNA, Bacterial; D009268:Nalidixic Acid; D016685:Mitomycin; D005664:Furazolidone; D009582:Nitrofurantoin